Ask Jonathan Rothberg a few questions about his new venture in DNA sequencing, and, ever the showman, he find references to a pivotal event in world history while delivering what amounts to a “no comment.” The questions were basic enough: How many employees do you have in San Francisco and Guilford, CT? How much has … Continue reading “Ion Torrent’s Fast and Cheap DNA Sequencer Catches On, Even as Biologists Tighten Belts”
Category: Boston
IPOs Look Dicey, But Private Equity May Pick Up Some Of The Slack
For a while, I was optimistic that 2011 would be a good year for venture capital-backed IPOs, and it wasn’t just wishful thinking. There were 72 VC-backed IPOs last year—six times as many as in 2009. The year ended with a bang and 2011 got off to a good start. In the first half of … Continue reading “IPOs Look Dicey, But Private Equity May Pick Up Some Of The Slack”
ProcessUnity Garners $920,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7b3d5785-4932-4d4f-bc2b-1449ed775f97&Preview=1 Date 9/15/2011 Company Name ProcessUnity Mailing Address 470 Totten Pond Road Waltham, MA 02451 Company Description ProcessUnity is a privately-held Risk Management solutions company headquartered along Route 128 in Waltham, Massachusetts, USA. Website http://www.processunity.com Transaction Type Venture Equity Transaction Amount $920,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. … Continue reading “ProcessUnity Garners $920,000 New Funding”
PharmaSecure Receives Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=565ff992-6dbb-4eaa-b784-1c7dd200efb7&Preview=1 Date 9/15/2011 Company Name PharmaSecure Mailing Address 16 Cavendish Court Lebanon, NH 03766 Company Description At PharmaSecure, our mission is twofold: to end the public health menace of pharmaceutical counterfeiting, and to help manufacturers communicate more effectively with their customers. Our systems cut out counterfeiters by creating a simple, secure, and … Continue reading “PharmaSecure Receives Series B Funding Round”
V.i. Laboratories Garners $500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=66d60233-ec68-4e57-ac17-816582984b75&Preview=1 Date 9/15/2011 Company Name V.i. Laboratories Mailing Address 130 Turner Street Building 3 5th Floor Waltham, MA 02453 Company Description V.i. Labs’ provides software protection solutions that secure valuable applications against piracy, tampering and code theft. Unlike other security technologies available today, our solutions protect applications without requiring modifications to the … Continue reading “V.i. Laboratories Garners $500,000 New Round”
EnerTrac Obtains $4,270,276 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c773bf0d-4ee3-478e-a351-c90b502fac6b&Preview=1 Date 9/15/2011 Company Name EnerTrac Mailing Address 94 River Road Hudson, NH 03051 Company Description Boston area-based, EnerTrac provides low cost, low bandwidth, remote monitoring for a variety of industries. Our mission is to accelerate the connection of Machine-to-Machine communication, just as cellphone technology has revolutionized the connections among people. Our … Continue reading “EnerTrac Obtains $4,270,276 New Funding”
California Dreamin’: TalkTo, Tasted Menu, Bluefin Robotics, and Burst Media Make Bicoastal Noise
[Updated 9/20/11. See below] The Silicon Valley vs. Boston tech scene discussion is a tired one, I know. But today we’ve seen a number of Boston-area companies make a splash with some significance to the San Francisco Bay Area. Here we go with the highlights: —Burst Media, the Burlington, MA-based online ad distributor now owned … Continue reading “California Dreamin’: TalkTo, Tasted Menu, Bluefin Robotics, and Burst Media Make Bicoastal Noise”
GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity
Earlier this year, Lexington, MA-based GI Dynamics faced a challenge that’s all too common these days in life sciences: It needed to raise $80 million to get through the next three years, and there are limited options for medical-device companies seeking that much cash. The company is developing a weight-loss device, and the money was … Continue reading “GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity”
10 Surprises of a First-Time Entrepreneur
As a young entrepreneur, I cannot overstate the importance of serendipity. I don’t know whether I’ll ultimately be successful or not, but the success I’ve had so far has been 10 percent inspiration, 90 percent perspiration, and 50 percent surprises. And if you’re saying that this adds up to 150 percent—you’re catching on to my … Continue reading “10 Surprises of a First-Time Entrepreneur”
PerkinElmer Acquires Caliper for $600M, VideoIQ Nabs $7.5M, MC10 Snags $2.5M, & More Boston-Area Deals News
Seems like Cambridge, MA, is buzzing with dollar signs. Many of the financings we spotted this week went to life sciences and Web companies in the city. —MC10, a Cambridge-based developer of technology enabling electronics to bend and stretch, added $2.5 million in Series B funding, bringing the round’s total to $14.75 million. The new … Continue reading “PerkinElmer Acquires Caliper for $600M, VideoIQ Nabs $7.5M, MC10 Snags $2.5M, & More Boston-Area Deals News”
AI Exchange Obtains $1,500,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b838ab86-0806-4483-80c0-4e3bcac2db06&Preview=1 Date 9/14/2011 Company Name AI Exchange Mailing Address One State Street Boston, MA 02109 Company Description AI Exchange, through its subsidiaries AI Advisors, LLC and AI Exchange Technologies, LLC, aims to revolutionize the way in which financial advisors and their clients access alternative investment strategies. For further information, please see the … Continue reading “AI Exchange Obtains $1,500,000 New Funding”
Acumentrics Garners $2,001,999 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=56c699c9-7267-4a51-816e-42d4baece005&Preview=1 Date 9/14/2011 Company Name Acumentrics Mailing Address 20 Southwest Park Westwood, MA 02090 Company Description The company quickly became an industry leader in rugged AC and DC uninterruptible power supplies (UPS) for military and industrial power conditioning and backup. Our RuggedUPS products are trusted in punishing environments found in war, heavy … Continue reading “Acumentrics Garners $2,001,999 New Financing”
meQuilibrium Lands $2,300,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=84dd54d8-6a84-4652-9b03-cc4e6e312943&Preview=1 Date 9/14/2011 Company Name meQuilibrium Mailing Address Undisclosed Boston, MA 01772 Company Description The meQuilibrium program was created to change how you think about yourself and your challenges. Your individual meQ score reflects the way you’re holding up – mentally, emotionally, physically, with your friends and family, with your work, and … Continue reading “meQuilibrium Lands $2,300,000 Series A Financing”
NABsys Receives $10,000,000 Series C Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c1c92eb5-3d8c-4175-93b3-ea63cef7dc40&Preview=1 Date 9/14/2011 Company Name NABsys Mailing Address 60 Clifford St Providence, RI 02903 Company Description NABsys aims to make whole-genome DNA sequencing fast, inexpensive, and accurate enough to be used in clinical care. Our approach builds on existing solid-state technologies to create a whole-genome sequencing technology that employs electronic detection, does … Continue reading “NABsys Receives $10,000,000 Series C Financing Round”
CEO Transitions at Boston-Power and Boston Scientific: Schmid Out at Battery Firm, Mahoney In at BSX
Interesting day for a couple of companies whose names start with “Boston.” Who’s next, Boston Dynamics? Boston Harbor Cruises? Maybe the Boston Red Sox. —Westborough, MA-based Boston-Power, a developer of advanced lithium-ion battery technology, saw three top executives leave last Friday, including CEO Keith Schmid. The news was first reported by Mass High Tech this … Continue reading “CEO Transitions at Boston-Power and Boston Scientific: Schmid Out at Battery Firm, Mahoney In at BSX”
Former Genzyme Boss Henri Termeer Gives $10M to MGH for Personalized Medicine
Henri Termeer, the former CEO of Cambridge, MA-based Genzyme, has given $10 million to Massachusetts General Hospital to establish a new center for developing more personalized cancer drugs, according to a report in today’s Boston Globe. The new Henri and Belinda Termeer Center for Targeted Therapies will initially focus on certain genetic forms of breast … Continue reading “Former Genzyme Boss Henri Termeer Gives $10M to MGH for Personalized Medicine”
Punchbowl, Priceline, and the Post Office: Some Consumer Tech News Around New England
When last we checked with Matt Douglas of Punchbowl, a Framingham, MA, startup known for its party-planning software, he was taking a bloggy swing at Seth Priebatsch of SCVNGR fame. Now he has set his sights on the greeting card industry and the U.S. Postal Service. Yes, with his startup’s latest product—a way for people … Continue reading “Punchbowl, Priceline, and the Post Office: Some Consumer Tech News Around New England”
Brigham and Women’s Teams Up With GNS Healthcare to Fend Off Adverse Events in Heart Patients
Boston-based Brigham and Women’s Hospital and its Center for Patient Safety Research and Practice, led by David Bates, are announcing today a collaboration with GNS Healthcare to use supercomputing technology to improve patient care. Cambridge, MA-based GNS Healthcare’s computer-simulation models will be used to predict the likelihood of adverse drug events and hospital readmission in … Continue reading “Brigham and Women’s Teams Up With GNS Healthcare to Fend Off Adverse Events in Heart Patients”
Mobile Platform Wars: What’s Next?
This has been the month of the handset. First, Google’s acquisition of Motorola Mobility, then HP’s effective exit from the handset business, and finally the sad news about Steve Jobs. These recent events kick off what I believe will be an accelerated pace of developments and re-shaping of the mobile device/platform ecosystem. Within the next … Continue reading “Mobile Platform Wars: What’s Next?”
Tensha Therapeutics Receives $15,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=487f8eeb-007d-4e09-8632-a70fdaac1d0f&Preview=1 Date 9/13/2011 Company Name Tensha Therapeutics Mailing Address 55 Cambridge Parkway Cambridge, MA 02142 Company Description Tensha Therapeutics is developing small molecule bromodomain inhibitors, a new class of epigenetic modulators of gene expression, to treat cancer and other serious disorders. Website http://www.tenshatherapeutics.com Transaction Type Venture Equity Transaction Amount $15,000,000 Transaction Round … Continue reading “Tensha Therapeutics Receives $15,000,000 Series A Financing Round”
TeraDiode, Laser Spinout from MIT Lincoln Lab, Beams Up New CEO
Some big changes are afoot at an interesting Boston-area laser startup. TeraDiode, a Littleton, MA-based maker of laser systems for cutting, welding, and defense applications, said today it has named Parviz Tayebati the company’s new CEO and board member. Tayebati, the former chief executive of telecom laser company Azna and photonics firm CoreTek, succeeds TeraDiode’s … Continue reading “TeraDiode, Laser Spinout from MIT Lincoln Lab, Beams Up New CEO”
Don’t Ask for Introductions to Investors
Raising money is hard, and there’s no way to screw it up faster than going around asking, “Hey, could you introduce me to some investors?” It’s sort of like when, on the second day of school, a goofy freshman asked me if I could introduce him to any girls. Reason 1: Not every investor is … Continue reading “Don’t Ask for Introductions to Investors”
Epigenetic Drug Startup Tensha Therapeutics Snags $15M Series A
Cambridge, MA-based drug developer Tensha Therapeutics announced today that it has snapped up $15 million in Series A funding from HealthCare Ventures. The funding will go to developing Tensha’s small molecule drug candidates, which are designed to treat cancer and other diseases by regulating the expression of disease-associated genes. Tensha’s drugs are inhibitors of so-called bromodomains, … Continue reading “Epigenetic Drug Startup Tensha Therapeutics Snags $15M Series A”
Genentech Seeks FDA Clearance for Next Skin Cancer Drug
Genentech is shipping off its latest application to the FDA to start selling a new cancer drug. This morning, the South San Francisco-based unit of Roche said it has filed paperwork for U.S. approval of vismodegib, a new drug for people with a deadly type of skin cancer that can’t be surgically removed. The drug, … Continue reading “Genentech Seeks FDA Clearance for Next Skin Cancer Drug”
Adtech Is Harmful to Consumers
If the ads on the websites and in the apps you frequent disappeared tomorrow, would you miss them? Can you think of any specific sites or apps, other than search, where introducing ads improved user experience? I happened upon these questions a few days ago while preparing the opening remarks for a FutureM event my … Continue reading “Adtech Is Harmful to Consumers”
VideoIQ Announces $7.5M, New CEO
Bedford, MA-based VideoIQ, a maker of video surveillance technology, announced today that it has pinned down $7.5 million in Series C funding, from Atlas Venture, Cisco, Matrix Partners and Tenaya Capital. The company reported $6 million in funding earlier this year in an SEC filing. It said today that the new funding will go to fueling … Continue reading “VideoIQ Announces $7.5M, New CEO”
Bluefin Labs, Named After a Sushi Bar, Tracks Social Media Around “Every Show on TV”
Deb Roy doesn’t strike me as a Jersey Shore kind of guy. Yet he can tell me exactly what viewers are saying about the estimable Deena Cortese during any episode, or how many people are annoyed by Mike “The Situation” Sorrentino and are tweeting about him (no, I haven’t been—too busy getting my GTL). I’ll … Continue reading “Bluefin Labs, Named After a Sushi Bar, Tracks Social Media Around “Every Show on TV””
What Most Biotechies Are Missing on Twitter: A Huge Networking Opportunity
Twitter is coming to biotech, it’s only a matter of time. And this is a truly wonderful thing. This thought occurred to me as I sat in my Seattle office, watching a video from a panel discussion of eight people in Boston—journalists, executives, venture capitalists, a PR person—who were talking about how biotechies can get … Continue reading “What Most Biotechies Are Missing on Twitter: A Huge Networking Opportunity”
Xconomy and WGBH Team Up to Cover the Boston Innovation Economy
Boston area radio listeners may have noticed something pretty cool on Friday morning: Xconomy’s on-air debut, during “Morning Edition” on WGBH’s 89.7. The Xconomy Report segment, which will be a regular feature Fridays at 7:49 am, is the product of a new partnership between us and WGBH Radio. It should come as no surprise that several … Continue reading “Xconomy and WGBH Team Up to Cover the Boston Innovation Economy”
Qstream Obtains $376,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dd4370ba-7b04-45c2-8edb-f9e503ceae9f&Preview=1 Date 9/12/2011 Company Name Qstream Mailing Address 15 New England Executive Park Burlington, MA 01803 Company Description Qstream is on a mission to change the face of learning for everyone. By bringing together an engaging, fun way to learn with a proven pedagogy developed at Harvard, Qstream is learning the way … Continue reading “Qstream Obtains $376,000 New Financing”
Arrien Pharmaceuticals Receives $2,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cc0e5581-d525-4d92-b266-f4809d104510&Preview=1 Date 9/12/2011 Company Name Arrien Pharmaceuticals Mailing Address 121 Wakelee Avenue Ansonia, CT 06401 Company Description Arrien Pharmaceuticals is a small molecule targeted therapeutics drug discovery and development company working towards targeting cell signaling pathways – A target class in treating neurodegenerative, Cancer, Inflammatory and Metabolic diseases. Website http://www.arrienpharma.com Transaction Type … Continue reading “Arrien Pharmaceuticals Receives $2,000,000 Series A Funding Round”
VideoIQ Obtains $7,500,000 Series C Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=186576ae-b237-43de-aa67-89013b47643f&Preview=1 Date 9/10/2011 Company Name VideoIQ Mailing Address 213 Burlington Road Bedford, MA 01730 Company Description VideoIQ acts as digital guard that transforms video surveillance into a dynamic, real-time, intelligent system for guarding against intruders, and gaining early warning of security breaches. It delivers the industry’s best detection accuracy and far fewer … Continue reading “VideoIQ Obtains $7,500,000 Series C Funding Round”
MTLC Member Roundtable: Google’s Agile Development Process and Strategies: A Case Study
This event comes as a celebration of the launch of Mass Technology Leadership Council’s software development cluster. A panel—representing companies like Autodesk, netBlazr, Kayak.com, and GSN—will discuss Google’s Agile development strategy. Sign up here.
The Tech World Deserves Better Than TechCrunch
Back in April 2009, community leaders in Boston were in a tizzy over the prospect of a shutdown at the Boston Globe, where unions were resisting salary and pension cuts proposed by the paper’s owner, the New York Times Co. I didn’t quite understand the leaders’ concerns. As a longtime admirer of the Globe, I … Continue reading “The Tech World Deserves Better Than TechCrunch”
BuyWithMe Buys Daily-Deals Site TownHog, Its Sixth Purchase of 2011
BuyWithMe, the New York- and Boston-based local deals startup, said today it has acquired TownHog, a San Francisco-based daily deals site owned by Dotblu. Terms of the deal weren’t disclosed. This is the sixth acquisition of the year for BuyWithMe, continuing a trend of consolidation in the local deals sector. Last month, CEO Jim Crowley … Continue reading “BuyWithMe Buys Daily-Deals Site TownHog, Its Sixth Purchase of 2011”
Take the Interview Takes In $775K for Job Screening Via Video
Score one for video-based recruiting and marketing. (Yes, there are a lot of startups in this sector, plus Skype and Google.) Cambridge, MA-based Take the Interview has closed $775,000 in seed funding this week from angel investors, as well as partners and limited partners of DreamIt Ventures, the startup incubator in New York City in … Continue reading “Take the Interview Takes In $775K for Job Screening Via Video”
American Innovators Lose Big in Newly Passed Patent Bill
American innovation lost big again as the U.S. Senate passed “patent reform” and caved to big business lobbyists at the expense of true innovators in small companies and universities. Bottom line: America has dominated innovation in the world for 100 years based on our patent system and protection of risk-takers. Innovation is the one thing … Continue reading “American Innovators Lose Big in Newly Passed Patent Bill”
BzzAgent’s FutureM TACOPOCALYPSE
BzzAgent is putting on this taco party as part of the FutureM week of events. Sign up here to get in on the free networking event.
Angel Capital Association Workshop
Entrepreneurs stay home; this workshop is targeted at angel investors and those looking to break into the arena. This session covers the topics of the overall angel investment process and due diligence. Register here.
Aura Adds $4.5M, Syndax To Present Breast Cancer Results at ASCO, PKE Buys Caliper, & More Boston-Area Life Sciences News
This week in New England we’ve seen financings and data updates from drug developers, as well as an acquisition in the life sciences tools space. —An SEC filing revealed that New Haven, CT-based BioRelix has brought in $3.6 million in new funding, as part of a round that could hit $5.3 million. The company is … Continue reading “Aura Adds $4.5M, Syndax To Present Breast Cancer Results at ASCO, PKE Buys Caliper, & More Boston-Area Life Sciences News”
Gen9 Garners $1,550,001 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7a59f1d-0c41-43e5-a2b2-225dcd047919&Preview=1 Date 9/9/2011 Company Name Gen9 Mailing Address 500 Technology Sq. Cambridge, MA 01239 Company Description The company is developing synthetic biology technologies. Website Undisclosed Transaction Type Venture Equity Transaction Amount $1,550,001 Transaction Round Series B Proceeds Purposes Proceeds purposes were not disclosed. Amount reflects value of Series B Preferred Stock to … Continue reading “Gen9 Garners $1,550,001 Series B Financing Round”
Take The Interview Obtains $775,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=70ba88d0-6937-4111-b4ee-b7f22681d231&Preview=1 Date 9/9/2011 Company Name Take The Interview Mailing Address 1 Cambridge Center 6th Floor Cambridge, MA 02142 Company Description The company is a cloud-based video interviewing platform provider. Website http://www.taketheinterview.com Transaction Type Venture Equity Transaction Amount $775,000 Transaction Round Seed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor … Continue reading “Take The Interview Obtains $775,000 Seed Funding Round”
HookLogic Raises $9.5M in Growth Capital, Will Nearly Double Staff
New York’s HookLogic said in a press release Thursday it raised $9.5 million in financing from Bain Capital Ventures in Boston. This marks the first institutional funding for HookLogic. Jonathan Opdyke, CEO of HookLogic, said in an interview with Xconomy the funding will help his company nearly double its staff. “We’ll hire at least 50 … Continue reading “HookLogic Raises $9.5M in Growth Capital, Will Nearly Double Staff”
Betaspring Unveils 11 New Startups from 2011 Summer Program at Demo Day
[Updated 3:00pm, see below] Providence, RI-based Betaspring, a seed-stage accelerator program in its third year, is holding its Investor Demo Day down in the Ocean State today. Eleven young startups, between three months and a year old, are presenting to an audience of venture capitalists, angel investors, entrepreneurs, and media. Looks like most (if not … Continue reading “Betaspring Unveils 11 New Startups from 2011 Summer Program at Demo Day”
Caliper To Be Acquired By PerkinElmer for $600M
Waltham, MA-based life sciences tools maker PerkinElmer (NYSE: [[ticker:PKI]]) announced this morning that it has agreed to acquire a Bay State neighbor focused on imaging and detection technology, Hopkinton, MA-based Caliper Life Sciences (NASDAQ: [[ticker:CALP]]), for $10.50 per share in cash. Caliper has a major office in Mountain View, CA, as well. The purchase, which comes … Continue reading “Caliper To Be Acquired By PerkinElmer for $600M”
Backupify Brings in $5M Series B
Cambridge, MA-based Backupify, a provider of technology for backing up data stored in e-mail and social media applications, is announcing it has nabbed a $5 million Series B financing, led by existing investor Avalon Ventures. Return investors General Catalyst Partners and Lowercase Capital also participated in the deal, which brings Backupify’s total funding pot to … Continue reading “Backupify Brings in $5M Series B”
Xconomist of the Week: Five Questions with Biocom CEO Joe Panetta
Joe Panetta is a 30-year biotech veteran on both sides of the interface between business and government regulators. He’s spent close to half of that time as president and CEO of Biocom, the San Diego-based regional life sciences industry association. Panetta also happens to be the latest member of the local innovation community to join … Continue reading “Xconomist of the Week: Five Questions with Biocom CEO Joe Panetta”
Aura Biosciences Raises $4.5M to Advance Nano-Drug Weapon Against Cancer
Today, Cambridge, MA-based Aura Biosciences announced that it has raised $4.5 million from a group of private investors. The funding brings the total amount raised by the two-year-old company to $8 million. Founder and CEO Elisabet de los Pinos won’t reveal details about the investors, except to say, “It’s a small group of wealthy individuals … Continue reading “Aura Biosciences Raises $4.5M to Advance Nano-Drug Weapon Against Cancer”
Arsenal Vascular Receives $12,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f9e0b9ee-afc0-4571-ac5a-06c1718258f5&Preview=1 Date 9/8/2011 Company Name Arsenal Vascular Mailing Address 480 Arsenal Street Watertown, MA 02472 Company Description Arsenal Vascular is a privately-held biotechnology company focused on the development of therapeutic products based on its proprietary BioActive Composites platform. Website http://www.arsenalmedical.com Transaction Type Venture Equity Transaction Amount $12,000,000 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Arsenal Vascular Receives $12,000,000 New Financing”
Aura Biosciences Obtains $4,500,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=991f129e-8dd2-4407-b6cf-20bcac5068e8&Preview=1 Date 9/8/2011 Company Name Aura Biosciences Mailing Address One Broadway 14th Floor Cambridge, MA 02142 Company Description Aura Biosciences is a next generation biotech company – combining the expertise of leading academic institutions through research and licensing agreements, with the flexibility and efficiency of a dedicated team of in-house scientists, deal-makers, … Continue reading “Aura Biosciences Obtains $4,500,000 Series B Funding”